Advertisement
Canada markets close in 17 minutes

  • S&P/TSX

    21,862.92
    -148.80 (-0.68%)
     

  • S&P 500

    5,073.53
    +2.98 (+0.06%)
     

  • DOW

    38,492.19
    -11.50 (-0.03%)
     

  • CAD/USD

    0.7300
    -0.0021 (-0.28%)
     

  • CRUDE OIL

    82.94
    -0.42 (-0.50%)
     

  • Bitcoin CAD

    88,164.10
    -3,005.71 (-3.30%)
     

  • CMC Crypto 200

    1,390.85
    -33.25 (-2.34%)
     

  • GOLD FUTURES

    2,334.90
    -7.20 (-0.31%)
     

  • RUSSELL 2000

    1,992.09
    -10.55 (-0.53%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ

    15,717.79
    +21.15 (+0.13%)
     

  • VOLATILITY

    15.70
    +0.01 (+0.06%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6818
    -0.0018 (-0.26%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Certara to Participate in Upcoming Investor Conferences

Certara
·1 min read
Certara
Certara

PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences:

•

Morgan Stanley 20th Annual Global Healthcare Conference

 

Date and Time: Tuesday, September 13 at 11:45 a.m. ET

 

 

•

Baird Global Healthcare Conference

 

Date and Time: Wednesday, September 14 at 12:15 p.m. ET

Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

ADVERTISEMENT

About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com